Target intelligence / Profile preview

Klebsiella pneumoniae surface polysaccharide

Molecular classification
Polysaccharide antigen, Surface virulence factor, Other
01

Overview

Klebsiella pneumoniae surface polysaccharide refers mainly to two major classes of surface-exposed carbohydrate polymers: the capsular polysaccharide (CPS, or K-antigen) and the O-antigen of lipopolysaccharide (LPS). The CPS forms a thick, protective capsule around the bacterium, composed of diverse repeating oligosaccharide units, and is one of the primary determinants of immune evasion, serum resistance, and virulence in K. pneumoniae. The O-antigen is the distal portion of LPS and contributes additional serotype diversity and immune evasion mechanisms. Both CPS and O-antigen are major targets for the development of vaccines, antibody therapies, and bacteriophage-based therapies. The antigenic diversity, especially for the capsule, presents a key challenge for broad-spectrum targeting, but these surface polysaccharides remain critical to bacterial survival, pathogenesis, and therapeutic targeting in drug-resistant and hypervirulent strains[1][2][4][6][7][8]. - The capsule (CPS) is the most important virulence factor and enables K. pneumoniae to resist phagocytosis and complement-mediated killing[1][3][6]. - Both CPS and O-antigen exhibit high structural variability, defining the serotype and affecting virulence and susceptibility to drugs, antibodies, and phages[1][2][7]. - Therapies targeting these polysaccharides include investigational CPS-based vaccines, monoclonal antibodies, and phage therapies; no approved CPS-based vaccines exist as of 2025[6][8]. - Surface polysaccharide expression and structure also correlate with biofilm formation, another key virulence trait complicating infections[5]. - This diversity and adaptability are at the core of K. pneumoniae's ability to cause serious, drug-resistant hospital-acquired infections.

Other names
Klebsiella pneumoniae surface antigenKlebsiella pneumoniae capsule polysaccharideKlebsiella pneumoniae capsular polysaccharideK-antigen (for capsule polysaccharide)O-antigen (for lipopolysaccharide)
02

Mechanism of action

Disruption of capsule integrity (e.g., by cationic peptides such as polymyxins)[4] Neutralization or opsonization by antibodies for enhanced immune clearance[6][8] Bacteriophage lysis by binding/recognizing surface polysaccharide antigens[2]

03

Biological functions

Immune evasionSerum resistanceBiofilm formationResistance to phagocytosisVirulence determinant
04

Disease associations

InfectionAntimicrobial resistanceOther
05

Safety considerations

Antigenic variability and high diversity complicating vaccine or drug design[1][2][7]Risk of immune escape or selection of non-capsulated mutants[4][6]Potential off-target effects and immune reactions to polysaccharide-based vaccines[6][8]
06

Interacting drugs

Polymyxins (e.g., polymyxin B, colistin)[4]

3 more in the full profile.

07

Biomarkers

Presence or abundance of K-antigen (CPS) type[1][7]Hypermucoidy/hypermucoviscosity (indicator of hypervirulent strains)[1][2]O-antigen (OPS/LPS) type[7]

Beyond the preview

Go deeper on Klebsiella pneumoniae surface polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klebsiella pneumoniae surface polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call